These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15146784)

  • 1. [New diagnostic procedures in gastroesophageal reflux disease: from the Bernstein test to impedance].
    Valdovinos Díaz MA; Gómez Escudero O
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():4-11. PubMed ID: 15146784
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and therapy of weakly-acid/non-acidic gastroesophageal reflux disease].
    Meining A; Bajbouj M; Stein HJ; Schmid RM
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2266-9. PubMed ID: 16208602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition and diagnosis of gastroesophageal reflux disease.
    Wong WM; Wong BC
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S26-32. PubMed ID: 15324379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [24-hour ph-metry of the esophagus].
    Schindlbeck N
    MMW Fortschr Med; 2003 Oct; 145(44):51-2. PubMed ID: 14655515
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multichannel intraluminal esophageal impedance: a new frontier in motility].
    de la Morena F; Santander Vaquero C; Cantero J; Pérez T; Moreno Otero R
    Rev Esp Enferm Dig; 2008 Feb; 100(2):86-9. PubMed ID: 18366266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics].
    Bossuyt PM
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):321-2; author reply 322. PubMed ID: 15730042
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impedance-pH analysis in gastroesophageal reflux monitoring].
    Szaflarska-Popławska A; Popławski C; Mierzwa G
    Pol Merkur Lekarski; 2007 Oct; 23(136):302-6. PubMed ID: 18293856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and therapy of reflux disease--early gastroscopy shows the way].
    Stiefelhagen P
    MMW Fortschr Med; 2006 Jul; 148(29-30):14. PubMed ID: 16913013
    [No Abstract]   [Full Text] [Related]  

  • 13. Technology insight: The role of impedance testing for esophageal disorders.
    Sifrim D; Blondeau K
    Nat Clin Pract Gastroenterol Hepatol; 2006 Apr; 3(4):210-9. PubMed ID: 16582963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peer review about gastro-esophageal reflux disease in primary care: epidemiology, diagnostic and therapeutic management].
    Belleri G; Comini L; Ramponi GP; Tabaglio E; Archetti G; Astori P; Baldini S; Baronchelli M; Beltrami G; Benini F; Bertolotti B; Bettoncelli G; Bonardelli E; Bovini L; Chiappi A; Ferrari A; Guarnera L; Mauro N; Multineddu M; Mutti E; Palini S; Palumbo M; Pascarella A; Pellizzari R; Regazzoli T; Sidari G; Terranova FR; Zadra A; Zavanella D
    Recenti Prog Med; 2006 Feb; 97(2):74-8. PubMed ID: 16671271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing.
    Kline MM; Ewing M; Simpson N; Laine L
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):880-5; quiz 836. PubMed ID: 18424190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid inhibition and gastroesophageal reflux disease.
    Sachs G
    Yale J Biol Med; 1999; 72(2-3):227-9. PubMed ID: 10780585
    [No Abstract]   [Full Text] [Related]  

  • 17. New developments in detection of gastroesophageal reflux.
    Emerenziani S; Sifrim D
    Curr Opin Gastroenterol; 2005 Jul; 21(4):450-3. PubMed ID: 15930987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal pH monitoring on PPI therapy: removing the blinders.
    Tutuian R; Mainie I; Castell DO
    Am J Gastroenterol; 2005 Aug; 100(8):1893-4; author reply 1894. PubMed ID: 16086728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.